HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02)

Kick&kill strategies combining drugs aiming to reactivate the viral reservoir with therapeutic vaccines to induce effective cytotoxic immune responses hold potential to achieve a functional cure for HIV-1 infection. Here, we report on an open-label, single-arm, phase I clinical trial, enrolling...

Full description

Bibliographic Details
Main Authors:	Mothe, B, Rosás-Umbert, M, Coll, P, Manzardo, C, Puertas, MC, Morón-López, S, Llano, A, Miranda, C, Cedeño, S, López, M, Alarcón-Soto, Y, Gómez Melis, G, Langohr, K, Barriocanal, AM, Toro, J, Ruiz, I, Rovira, C, Carrillo, A, Meulbroek, M, Crook, A, Wee, EG, Miró, JM, Clotet, B, Valle, M, Martinez-Picado, J, Hanke, T, Brander, C, Moltó, J, BCN02 Study Investigators
Format:	Journal article
Language:	English
Published:	Frontiers Media 2020

HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02)

Similar Items